Cerebrospinal fluid β2-microglobulin in neuro-Behçet’s syndrome
Introduction
Central nervous system (CNS) involvement in Behçet’s disease, usually called neuro-Behçet’s syndrome (NB), is one of the most serious complications of the disease [1], [2]. The neurological involvement is either caused by primary neural parenchymal lesions (neuro-Behçet’s syndrome) or secondary to major vascular involvement [3], [4]. The latter type is rarely complicated with the former type and should be called vasculo-Behçet’s disease [3]. Although a lot of efforts have been made, the etiology and pathogenesis of NB still remain unclear. Previous studies have demonstrated that cerebrospinal fluids (CSF) from patients with NB show characteristic features analogous to those observed in patients with infectious meningoencephalitis (IM), including marked pleocytosis, breakdown of the blood–brain barrier, and elevation of CSF IgM index [5]. Moreover, it has also been disclosed that CSF from patients with active NB have increased levels of interleukin 6 (IL-6) [6], which has been also found to be elevated in CSF from IM [7].
β2-Microglobulin (β2MG) is a low molecular weight protein non-covalently bound to the major histocompatibility complex class I molecule [8]. Previous studies have shown that CSF β2MG was elevated in patients with various neurological diseases, including IM [9], neurosarcoidosis [10], and AIDS dementia complex [11]. However, the kinetics of CSF β2MG have not been fully elucidated in patients with NB. The current studies were therefore designed to explore the levels of β2MG in sera and CSF from patients with NB, in order to delineate the role of β2MG in the pathogenesis of NB.
Section snippets
Patient and samples
The CSF samples were obtained by lumbar puncture from 17 patients with Behçet’s disease (14 males and three females, aged 17–68 years old), who had satisfied the international diagnostic criteria for Behçet’s disease [12]. All the patients also had symptoms or signs of CNS involvement, which were attributed to active Behçet’s disease after careful evaluation (Table 1) [6], [13]. Of the 17 patients, six patients showed acute meningoencephalitis or meningitis as evidenced by the elevation of cell
Results
The concentrations of β2MG in the CSF and sera from patients with NB and control patients are shown in Fig. 1. Both CSF β2MG and serum β2MG were significantly elevated in patients with NB compared with control patients. Of note, CSF β2MG was not correlated with either serum β2MG or Q albumin in control patients, whereas CSF β2MG was significantly correlated with serum β2MG in NB patients (Fig. 2). Although CSF β2MG was not significantly correlated with Q albumin in NB patients, it is likely
Discussion
The current studies disclosed that the levels of β2MG in CSF as well as in sera from patients with NB were significantly elevated compared with control patients. Since there was no other factor that resulted in the elevation of serum β2MG, such as renal damage, the elevation of serum β2MG in NB patients might be related with the systemic disease activity of Behçet’s disease, as is consistent with the previous study [18]. In fact, most of our patients showed recurrent attacks of systemic
Acknowledgements
The authors wish to thank Tomohide Satoh, MD, Chief Professor of Internal Medicine, and Takashi Hashimoto, MD, for encouragement and helpful advice, Tamiko Yanagida, PhD, for technical assistance, and Chise Kawashima for assistance in preparing the manuscript and the illustrations. Supported by 1999 grant (C) 30082142 from the Ministry of Education, Culture, Science and Sports of the Japanese Government.
References (20)
- et al.
The β2-microglobulin content of the cerebrospinal fluid in neurological disease
J Neurol Sci
(1977) - et al.
Cerebrospinal fluid lysozyme and β2-microglobulin in neurosarcoidosis
J Neurol Sci
(1986) - et al.
Cerebrospinal fluid interleukin-6 in progressive neuro-Behçet’s syndrome
Clin Immunol Immunopathol
(1997) - et al.
Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behçet’s disease
J Neurol Sci
(1998) - et al.
A case of neuro-Behçet’s syndrome
- et al.
Involvement of nervous system in Behçet’s syndrome
Arch Neurol
(1965) Behçet’s disease and the nervous system
J Neurol
(1998)- et al.
Neurological complications in Behçet’s syndrome
Brain
(1999) - et al.
Association of cerebrospinal fluid IgM index with central nervous system involvement in Behçet’s disease
Arthritis Rheum
(1986) - et al.
Elevated levels of interleukin 6 in cerebrospinal fluid from patients with neuro-Behçet’s syndrome
Cited by (27)
The clinical spectrum of the neurological involvement in vasculitides
2009, Journal of the Neurological SciencesConnective Tissue, Endocrine, Toxic, and Psychiatric Disorders
2009, Cerebrospinal Fluid in Clinical PracticeEffect of infliximab in progressive Neuro-Behçet's syndrome
2008, Journal of the Neurological SciencesHistopathology of central nervous system lesions in Behçet's disease
2008, Journal of the Neurological Sciences